Anti-CEA-CAR T (Southwest Hospital)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAnti-CEA-CAR T (Southwest Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesThe Southwest Hospital of AMU
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Southwest Hospital of AMU
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A